HuGE Literature Finder
Records
1
-
3
Molecular Analysis of the SRD5A1 and SRD5A2 Genes in Patients with Benign Prostatic Hyperplasia with Regard to Metabolic Parameters and Selected Hormone Levels. International journal of environmental research and public health 2017 Oct 14 (11): . Ry? Aleksandra, Rotter Iwona, Grzywacz Anna, Ma?ecka Iwona, Skonieczna-?ydecka Karolina, Grzesiak Katarzyna, S?ojewski Marcin, Szyli?ska Aleksandra, Sipak-Szmigiel Olimpia, Piasecka Ma?gorzata, Walczakiewicz Kinga, Laszczy?ska Mar |
SRD5A1 and SRD5A2 are associated with treatment for benign prostatic hyperplasia with the combination of 5a-reductase inhibitors and a-adrenergic receptor antagonists. The Journal of urology 2013 Mar . Gu X, Na R, Huang T, Wang L, Tao S, Tian L, Chen Z, Jiao Y, Kang J, Zheng S, Xu J, Sun J, Qi J |
A case-based evaluation of SRD5A1, SRD5A2, AR, and ADRA1A as candidate genes for severity of BPH. The pharmacogenomics journal 2004 4 (4): 251-9. Klotsman M, Weinberg C R, Davis K, Binnie C G, Hartmann K |
- Page last reviewed:Feb 1, 2023
- Page last updated:Feb 01, 2023
- Content source: